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The increase of fatty acid-binding protein aP2 in overweight and
obese children: interactions with dietary fat and impact on
measures of subclinical inflammation
Abstract
BACKGROUND: In adults, circulating aP2 may link obesity, inflammation and the metabolic
syndrome, but there are few data in children. Experimental models support that dietary factors,
particularly dietary fat, may be major determinants of phenotype. OBJECTIVE: The aim of this study
was to investigate, in normal, overweight and obese children, the relationships among aP2, the
metabolic syndrome, inflammation and diet. DESIGN: This was a cross-sectional study conducted in
Northern Switzerland. SUBJECTS: Subjects for this study were 6- to 14-year-old, prepubertal and early
pubertal, normal weight, overweight and obese children (n=124). MAIN OUTCOME MEASURES:
Body mass index (BMI), body fat percent, waist-to-hip ratio, blood pressure, circulating aP2, fasting
insulin, C-reactive protein (CRP), plasma lipids and dietary intakes of macro- and micronutrients were
determined. RESULTS: Circulating aP2 markedly increased with increasing central and total adiposity,
and predicted measures of insulin resistance. Independent of BMI standard deviation scores and puberty,
aP2 correlated with intake of the antioxidant vitamins A, C and E as well as circulating concentrations
of CRP, leptin and low-density lipoprotein cholesterol. Children with lower aP2 concentrations
consuming high-fat diets did not show an increase in fasting insulin or CRP, whereas those with higher
aP2 concentrations showed marked increases in these measures with high intakes of fat or saturated fat.
CONCLUSIONS: Increased central and overall adiposity in children are associated with higher
circulating aP2 concentrations. In children with high dietary intakes of total fat and saturated fat, but not
those with low intakes, higher aP2 concentrations are associated with measures of insulin resistance and
inflammation.
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Abstract 
Background In adults, circulating aP2 may link obesity, inflammation and the 
metabolic syndrome, but there are few data in children. Experimental models support 
that dietary factors, particularly dietary fat, may be major determinants of phenotype.  
Objective The aim of this study was to investigate, in normal-, overweight and obese 
children, the relationships between aP2, the metabolic syndrome, inflammation and 
diet. 
Design This was a cross-sectional study. 
Setting The study was conducted in Northern Switzerland. 
Subjects Subjects for this study were 6- to 14-year old, prepubertal and early 
pubertal, normal weight, overweight and obese children (n=124). 
Main Outcome Measures Body mass index, body fat %, waist-to-hip ratio, blood 
pressure, circulating aP2, fasting insulin, C-reactive protein, plasma lipids and dietary 
intakes of macro- and micronutrients were determined. 
Results Circulating aP2 markedly increased with increasing central and total 
adiposity, and predicted measures of insulin resistance. Independent of BMI-SDS 
and puberty, aP2 correlated with intake of the antioxidant vitamins A, C and E as well 
as circulating concentrations of CRP, leptin and LDL-cholesterol. Children with lower 
aP2 concentrations consuming high-fat diets did not show an increase in fasting 
insulin or CRP, while those with higher aP2 concentrations showed marked 
increases in these measures with high intakes of fat or saturated fat. 
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Conclusions Increased central and overall adiposity in children are associated with 
higher circulating aP2 concentrations. In children with high dietary intakes of total fat 
and saturated fat, but not those with low intakes, higher aP2 concentrations are 
associated with measures of insulin resistance and inflammation. 
 
Abbreviations 
%BF body fat percentage 
aP2 adipocyte fatty acid binding protein (FABP4) 
BMI SDS body mass index standard deviation scores 
BMI body mass index 
CRP C-reactive protein 
FFA free fatty acid 
HDL high density lipoprotein 
IL-6 interleukin 6 
LDL low density lipoprotein 
MUFA monounsaturated fatty acid 
PUFA polyunsaturated fatty acid 
QUICKI quantitative insulin sensitivity check index 
SFA saturated fatty acid 
TNFα tumor necrosis factor α 
W/H ratio waist to hip ratio 
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Introduction 
The adipocyte–fatty acid binding protein aP2 (FABP4) is a ≈15-kDa protein 
abundantly expressed by adipocytes and also present in macrophages (1-3). In these 
tissues, it plays a role in fatty acid, cholesterol and phospholipid metabolism. The 
function of circulating aP2 is unclear, but it may link obesity, inflammation and the 
metabolic syndrome (3). In adult studies, circulating aP2 concentrations correlate 
with insulin resistance and dyslipidemia (4-6) and predict development of the 
metabolic syndrome (7). aP2 has been linked to inflammation in atherosclerotic 
lesions (2, 8, 9) and in allergic airway disease (10). 
aP2-deficient mice given normal diets have a normal phenotype, but when fed high-
fat diets are protected against insulin resistance and dyslipidemia (11, 12). In 
apolipoprotein E–deficient mice, deletion of the aP2 gene reduces atherosclerosis 
and increases survival in the face of a high-fat diet (2). Thus, in aP2–/– animals, 
dietary factors, particularly dietary fat, are the major determinant of phenotype.  
The prevalence of childhood obesity is increasing and is closely linked to the 
metabolic syndrome and subclinical inflammation. There are few published data on 
aP2 in children and, although dietary factors are central determinants of phenotype in 
aP2-deficient animals, no studies have examined the relationship between dietary 
intakes and the effects of circulating aP2 in humans. Therefore, the aim of this study 
was to investigate, in normal- and overweight children, the relationships between 
aP2, the metabolic syndrome, inflammation and diet.  
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Subjects and Methods 
The subjects for this study were 6-14 yr-old children (n=124), living in northern 
Switzerland. The children were a convenience sample recruited in two steps (first 
step n=72, second step n=52) through letters to both primary schools and 
pediatricians. Data collection started in spring 2005 and was finished in fall 2007. The 
children recruited through pediatricians were otherwise healthy overweight and 
obese children not yet enrolled in a weight loss program. Data on subclinical 
inflammation, retinol binding protein (RBP)4 and LDL-particle size from a subgroup of 
these children (n=79) has been published previously (13-15). Informed written 
consent was obtained from the parents and informed oral assent from the children. 
Ethical approval for the study was obtained from the ethics committee of the Swiss 
Federal Institute of Technology in Zürich. 
 
Dietary assessment was done using two 24-hr recalls and a 1-day weighed food 
record in the first group of children (n=72) and two 24-hour recalls combined with one 
3-day weighed food record in the second group of children (n=52). All interviews 
were done by well-trained female interviewers in the family home. Each child was 
visited twice by the same interviewer within three weeks. The 24-hour recalls were 
done at each visit and, at the first visit, the interviewer gave instructions and 
guidelines for the weighed food record. At the second visit, the weighed food record 
was carefully reviewed. Volumes and portion sizes for the 24-hour recalls were 
estimated using photographs of different portions of a variety of foods and meals. 
Combining 24-hour recalls and a food record provides a good overview of a child’s 
habitual diet; this approach has been validated in children as young as 8 yrs of age 
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(16). An appointment was scheduled at the hospital clinic, at the parents’ 
convenience, usually within 1-2 weeks of the dietary assessment. 
 
The children presented to the hospital clinic in the morning after a 12 hr overnight 
fast. Twelve ml of blood were taken by venipuncture. Height was measured to the 
nearest 0.5 cm and weight to the nearest 100 g using a digital balance (Beurer BF 
18, Ulm, Germany). Pubertal staging was done by presenting drawings of the 
different Tanner stages to the child and the parents. Waist and hip circumferences 
were measured using a nonstretchable measuring tape. Skinfold thicknesses were 
measured at the biceps, triceps, suprailiacal and subscapular sites using a 
Harpenden Skinfold Caliper (HSK-BI; British Indicators, West Sussex, United 
Kingdom) with a constant spring pressure of 10 g/mm2 and a resolution of 0.2 mm. 
After a fifteen minute rest, resting blood pressure was measured manually by 
auscultation with the children sitting in the examination chair. 
 
Data analysis 
Dietary data obtained from the three records were thoroughly checked and entered 
into a nutrition software system (EBISpro for Windows 4.0, Dr. J. Erhardt, University 
of Hohenheim, Germany). This system translates the amount of food eaten into 
individual nutrients and assigns consumed foods into 22 food groups. The program is 
based on the German Food and Nutrition Data Base BLS 2.3 (Federal Health 
Department, Berlin, Germany), and, for foods specific to Switzerland, incorporates 
values from the Swiss Food Composition Database (17). Energy and nutrient data 
were averaged across the three or five days to obtain a mean daily energy and 
nutrient intake for each child. The reference values for nutrient intake for Germany, 
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Austria and Switzerland, the D-A-CH references (18), were used for comparison of 
the actual intake to the recommendations for the respective age groups. 
 
Body mass index (BMI) of the children was calculated as weight (kg) / height (m) 2. 
To scale the data for comparison across ages and sex, BMI standard deviation 
scores (BMI-SDS: individual BMI value – reference mean BMI value divided by SD) 
were calculated using the program Epi Info (Version 3.4.1) and the reference values 
proposed by the U.S. Centers for Disease Control and Prevention (CDC) in 2000. 
Age and gender specific criteria also from CDC (19) were used to classify children as 
normal weight, overweight (between the 85th and the 95th percentile) or obese (above 
the 95th percentile). These criteria have been previously validated in Swiss children at 
this age (20). Body density (D) and body fat percentage (%BF) were calculated 
according to the following equations by Deurenberg et al. (21) using the four 
measured skinfold thicknesses: 
)(0788.01690.1]/[)( SFTfourofSumLogmlgboysD ⋅−=  
)(0999.02063.1]/[)( SFTfourofSumLogmlggirlsD ⋅−=  
))2(7.4525()2(2.4562[%] −⋅−−⎟⎟⎠
⎞
⎜⎜⎝
⎛ −⋅−= age
densitybody
agefatbody  
 
Laboratory analysis 
Glucose was measured immediately using reflection photometry (Reflotron® Sprint, 
Roche, Switzerland). On fresh serum HDL- and LDL cholesterol and triglycerides 
were measured on Hitachi 917 (TriglycerideGPO-PAP and HDL-C / LDL-C plus 2nd 
generateion, Roche, Switzerland). Serum was stored at -20°C for later determination 
of aP2 (Human Adipocyte FABP ELISA, BioVendor GmbH, Heidelberg, Germany), 
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insulin (radioimmunoassay, SCHERING (Schweiz) AG, Baar, Switzerland), high 
sensitivity CRP (chemiluminescent immunometry, IMMULITE® Bühlmann 
Laboratories AG, Switzerland), IL-6 (high sensitivity ELISA, Quantikine HS Human IL-
6 Immunoassay, R&D Systems, Minneapolis, USA), Leptin (Leptin (human) ELISA 
Kit, BioVender, Alexis Biochemicals, Lausen, Switzerland) and free fatty acids (NEFA 
C Assay Kit, Wako Chemicals, Neuss, Germany). Interleukin 6 (IL-6), leptin and free 
fatty acids were done on a subgroup of 72 children. For all children, the quantitative 
insulin sensitivity check index (QUICKI), was calculated as follows: QUICKI = 1 / 
(log(fasting insulin mU/l) + log(fasting glucose mg/dl)) (22). 
 
Statistical analysis 
Statistical analysis was performed using the statistical package SPSS 13.0 for 
Windows (SPSS Chicago, Illinois, USA). Non-normally distributed variables were log-
transformed for comparisons. Normally distributed data are presented as means ± 
SD and non-normally distributed data as medians (range). One way ANOVA with a 
post-hoc Bonferroni Test was used to compare means. Multiple regression models 
were used to study the effect of nutrients, metabolic and personal covariates on 
metabolic variables, focusing on aP2. All equations were checked for confounding 
factors like adiposity, age, puberty and gender and they were added as covariates if 
they were significant predictors. 
Results 
In Table 1 the anthropometric and metabolic data of the children are shown by weight 
classification. aP2 concentrations were significantly higher in overweight and obese 
children, as well as in those children with greater waist to hip ratio (W/H ratio) (Figure 
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1). There were highly significant correlations between aP2 and all three measures of 
adiposity in univariate correlations (BMI-SDS r=0.669, p<0.001; W/H ratio r=0.499, 
p=<0.001 and %BF r=0.750, p=<0.001) as well as after controlling for age, gender 
and puberty (BMI-SDS (controlled for puberty only) β=0.629, p<0.001, W/H ratio 
β=0.532, p<0.001, %BF β=0.752, p<0.001). 
Dietary intake data of the three groups of children by weight classification are listed in 
Table 2. Although there were no significant differences in energy intake by weight 
classification, there were significant differences between groups in intakes of 
saturated fatty acids, % energy as protein, meat products, and total vitamin A 
(p<0.05).  
In univariate correlations, aP2 was associated with pubertal stage (r=0.325, p<0.001) 
and multiple components of the metabolic syndrome: fasting insulin (r=0.444, 
p<0.001), QUICKI (r=-0.436, p<0.001), systolic blood pressure (r=0.354, p<0.001), 
diastolic blood pressure (r=0.266, p=0.005), triglycerides (r=0.380, p<0.001), HDL-
cholesterol (r=-0.170, p=0.059) and LDL-cholesterol (r=0.338, p<0.001). It was also 
associated with inflammatory markers (C-reactive protein (CRP) (r=0.413, p<0.001), 
IL-6 (r=0.352, p=0.002), leptin (r=0.753, p<0.001). Although there was no association 
between FFA and aP2 concentrations, higher FFAs were correlated with two 
measures of insulin sensitivity: FFAs were directly correlated with QUICKI (.311, 
p=0.008) and indirectly correlated with fasting insulin (-.282, p=0.016). Tables 3 and 
4 show the univariate and multivariate (controlled for BMI-SDS and puberty) 
associations between aP2 and components of the metabolic syndrome and 
inflammatory markers. After controlling for adiposity and puberty, aP2 remained 
significantly associated with LDL-cholesterol, CRP and leptin. 
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Circulating aP2 correlated with several dietary factors: glucose (r=-0.196, p=0.030), 
fructose (r=-0.184, p=0.041), fruits and vegetables (r=-0.183, p=0.042), vitamin C (r=-
0.215, p=0.017), vitamin A (r=-0.271, p=0.002) and vitamin E (r=0.439, p<0.001). 
After controlling for BMI-SDS and pubertal stage, the antioxidant vitamins A (β=-
0.137, p=0.040), C (β=-0.156, p=0.017) and E (β=0.249, p<0.001) remained 
associated with aP2.  
The interactions between aP2, dietary fat and saturated fat intake and measures of 
insulin resistance (fasting insulin) and inflammation (CRP) are shown in Figure 2. In 
children with low circulating aP2 concentrations, there was no significant increase in 
fasting insulin or CRP at higher intakes of fat and saturated fat. In contrast, in 
children with higher circulating aP2, fasting insulin and CRP increased sharply with 
increasing fat or saturated fat intake. The tertiles of aP2 as displayed in Figure 2 
were (median (range)) 7.69 (4.63-10.64) ng/ml, 14.29 (10.79-20.45) ng/ml and 27.54 
(20.53-64.08) ng/ml. For the intake of fat in % of energy the tertiles were 31 (25-
33)%, 36 (33-37)% and 40 (37-53)% and for the intake of saturated fat as % of 
energy they were 11.8 (8.0-13.3)%, 14.4 (13.3-15.4)% and 16.6 (15.4-22.3)%. For 
example, Figure 2b shows that children in the lower tertile for aP2 show a small non-
significant decrease in fasting insulin concentrations at higher saturated fat intakes; 
in contrast, those in the middle and upper tertiles for aP2 show a 60-150% increase 
in fasting insulin at higher intakes. This interaction between fat intake, aP2 and 
inflammation was also evident in regression analysis: aP2 was a significantly 
associated with CRP (r=0.413) and adding dietary fat or saturated fat to the 
regression significantly improved the model (% energy as fat: p=0.001, β=0.281, 
R=0.500; % energy as SFA: p=0.049, β=0.171, R=0.447), as did addition of vitamins 
A and C (r=0.443). 
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Discussion 
Our findings demonstrate circulating aP2 concentrations are markedly elevated in 
overweight and obese 6-14 y-old children. BMI, %BF and W/H ratio were, 
independent of age, gender or puberty, were all positively associated with higher aP2 
concentrations, suggesting both total and central adiposity are linked to circulating 
aP2. Higher aP2 concentrations were also significantly correlated with most other 
components of the metabolic syndrome, including higher blood pressure, higher 
triglycerides, measures of insulin resistance, as well as multiple markers of 
subclinical inflammation.  
These findings are generally consistent with findings of previous adult studies. In 
adults with type 2 diabetes, aP2 was positively correlated with adiposity, SBP, CRP, 
triglycerides, and diabetes duration, but not with circulating insulin or glucose (5). In 
adults with the metabolic syndrome, aP2 serum level correlated with fasting levels of 
insulin, glucose, triglycerides, BMI and waist circumference, but negatively with HDL 
cholesterol and QUICKI (6). Women who carry a functional genetic variant of the aP2 
gene that reduces adipose tissue aP2 gene expression have a reduced risk for type 2 
diabetes and coronary artery disease (23). In a 5-yr prospective study in Chinese 
adults, controlling for insulin resistance and body mass index (BMI), baseline aP2 
was a highly significant independent predictor of the development of the metabolic 
syndrome (7). 
Our findings differ from those of a previous study in 30 obese German children (24), 
where aP2 correlated significantly to SDS-BMI and leptin, but not age, sex, pubertal 
stage, lipids, blood pressure, fasting glucose, insulin or CRP and TNF-α. These 
differences may be explained in part by differences in adiposity (our sample included 
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both normal and overweight children), age and pubertal development (our sample 
was slightly younger and mainly pre-pubertal), or may be due to the small sample 
size and a possible β error in the study by Reinehr et al (24). 
aP2 in macrophages have been suggested to mediate the inflammation of 
atherosclerosis and allergic airway disease (2, 8-10). This effect may be due to 
regulation of PPARγ and NF-κB in macrophages (25, 26) and/or through binding to 
and reducing turnover of long-chain fatty acids, such as arachidonic acid and 
leukotriene A4 (27, 28). In adults with type 2 diabetes, aP2 is directly correlated with 
CRP concentrations (5). The present study is the first to link aP2 to inflammation in 
children: independent of adiposity, aP2 concentration was significantly correlated 
with CRP, a downstream marker of subclinical inflammation. It was also associated 
with circulating levels of the proinflammatory adipokines leptin and IL-6. Although 
none of the children reported allergic airway disease, obese children have higher risk 
of asthma than normal weight children; this effect could be due to differences in aP2-
mediated inflammation (10).  
Variations in dietary fat are the major determinant of phenotype in aP2-deficient 
animals (2, 12). aP2-deficient mice eating normal rat chow grow and develop 
normally (12). However, when fed a high-fat Western diet that is diabetogenic and 
atherogenic in control animals, they have lower cholesterol and triglyceride levels, 
and are protected against insulin resistance and atherosclerosis (2, 12). The present 
data show a remarkably similar pattern. In children with lower circulating aP2 levels, 
higher intakes of saturated and total fat were not associated with fasting insulin or 
CRP (Figure 2). In contrast, children with higher aP2 concentrations display markedly 
elevated insulin and CRP concentrations at higher fat intakes. Human studies also 
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suggest genetic factors play a role in determining aP2 phenotype and that individuals 
expressing low levels of aP2 are to some degree protected from the development of 
insulin resistance and coronary heart disease (23).  
 
Consumption of high amounts of fat increases the pool of circulating FFAs. Increased 
circulating FFAs in obesity are thought to contribute to insulin resistance and 
inflammation (29-31). Paradoxically, FABP–/– mouse models are more insulin 
sensitive despite higher levels of circulating FFAs (12, 32, 33). Similarly, in our data 
higher FFAs were associated with two measures of insulin sensitivity (QUICKI and 
fasting insulin),: but there was no correlation between circulating FFA and aP2 
concentrations. Although circulating FFA concentrations rise after the ingestion of 
meals high in fat or rapidly-digestible starches (34, 35), in our data, we found no 
correlations of fasting FFA concentrations and any measured dietary factors, 
including total fat or carbohydrate type. However, such an effect might be visible 
postprandially. 
 
Dietary intakes of the antioxidant vitamins A and C were negatively correlated with 
aP2, after controlling for adiposity and puberty. Expression of aP2 in cholesterol-
loaded THP-1 macrophages is stimulated by oxidized low density lipoprotein, an 
effect inhibited by treatment of the cells with an antioxidant inhibitor of NF-κB (36, 
37). Dietary antioxidants can reduce oxidation of LDL-cholesterol (38), and this 
mechanism may explain why circulating aP2 was lower in children with higher intakes 
of vitamins A and C. The present data also suggest an interaction between 
antioxidant vitamin intake, aP2 and inflammation. In regression analysis, aP2 was 
significantly positively associated with CRP and the model including vitamins A and C 
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suggested that when aP2 concentrations are high, increasing vitamin A and C 
intakes is associated with lower CRP concentrations.  
 
We found no differences in mean energy intakes by weight classification, despite the 
fact that if energy requirements were based only on body size, we would have 
expected higher energy intakes in the overweight and obese children to maintain 
their body weight. Similar findings have also been reported in previous studies ((39, 
40) and could be due to several factors. It is possible that the results were 
confounded by underreporting, which may be more common in overweight and 
obese individuals (41). However, we tried to minimize significant underreporting by 
excluding 9 children who reported energy intakes less than their RMR multiplied by a 
minimal physical activity level of 1.2 (42). Alternatively, the overweight and obese 
children may have been limiting their energy intakes in an attempt to control their 
weight. Another explanation may be that physical activity levels were higher in the 
normal weight children, as has been previously shown in Swiss children at this age 
(43) and this may be result in higher energy requirements to maintain body weight.    
 
In summary, increased central and overall adiposity in 6-14 y-old children were 
associated with higher circulating aP2 concentrations. In children with high dietary 
intakes of total and saturated fat, but not those with low intakes, higher aP2 
concentrations were associated with measures of insulin resistance and 
inflammation. Because childhood obesity increases risk for diabetes and 
atherosclerosis in late adolescence and adulthood, our findings argue that weight-
loss interventions at this age, particularly in children with higher aP2 concentrations, 
should emphasize reductions in dietary intakes of total fat and saturated fat. 
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Table 1 Anthropometric and metabolic data of 6- to 14-year old Swiss children by 
weight classification 
 
 Normal weight1 Overweight1 Obese1 
n 38 36 50 
Age (yr) 10.35 ± 1.89 2,a 10.70 ± 1.75 a 9.93 ± 1.84 a 
Gender ratio (m/f) 15/23 19/17 25/25 
BMI (kg/m2) 16.6 ± 2.0 a 21.8 ±2.2 b 25.7 ± 3.9 c 
BMI-SDS -0.39 ± 1.01 a 1.35 ± 0.20 b 2.05 ± 0.26 c 
Body fat % 19.9 ± 5.0 a 32.7 ± 6.1 b 38.5 ± 5.8 c 
Waist to hip ratio 0.80 ± 0.04 a 0.83 ± 0.06 b 0.89 ± 0.05 c 
Tanner stage (no. 
of children) 
   
Stage I 21 12 22 
Stage II 13 16 19 
Stage III 2 2 5 
Stage IV 2 6 4 
aP2 (ng/ml) 8.12 (4.63-28.41) 
3,a 
15.60 (6.43-64.08) 
b 
20.49 (7.80-52.66) c
Fasting insulin 
(pmol/l) 
82.5 (25.0-451.0) a 110.0 (52.0-230.0) 
b 
161.0 (68.0-778.0) c
QUICKI 0.34 ± 0.02 a 0.32 ± 0.02 b 0.30 ± 0.02 c 
CRP (mg/dl) 0.03 (0.01-0.42) a 0.09 (0.03-0.99) b 0.15 (0.03-2.25) c 
Triglycerides 
(mmol/l) 
0.5 (0.3-2.1) a 0.8 (0.3-1.5) b 0.9 (0.3-2.2) c 
HDL cholesterol 
(mmol/l) 
1.59 ± 0.25 a 1.51 ± 0.30 a,b 1.40 ± 0.34 b 
LDL cholesterol 
(mmol/l) 
2.38 ± 0.58 a 2.83 ± 0.68 b 2.75 ± 0.77 b 
Free fatty acids 
(μmol/l) 4 
754.0 ± 265.6 a 686.8 ± 226.7 a 644.2 ± 301.0 a 
IL6 (pg/ml) 4 0.3 (0.1-1.8) a 0.4 (0.1-2.0) a,b 0.8 (0.1-2.1) b 
Leptin (ng/ml) 4 1.88 (0.11-15.52) a 9.79 (1.78-62.87) b 22.38 (8.98-62.12) c
Systolic blood 
pressure (mm Hg) 
98.1 ± 9.0 a 105.4 ± 12.2 b 110.8 ± 12.6 b 
Diastolic blood 
pressure (mm Hg) 
64.6 ± 8.4 a 64.4 ± 12.2 a 70.4 ± 8.6 b 
Means not sharing a common superscript letter are significantly different from each 
other at p<0.05 (ANOVA with post hoc Bonferroni correction) 
1 Normal weight, overweight and obesity were defined according to the age and 
sex specific criteria defined by Ogden et al (19) 
2 Mean ± SD (all such values) 
3 Median (range) all such values 
4 Parameters only measured in a total of 72 children (29 nw, 17 ow, 26 ob) 
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Table 2 Dietary intake of 6- to 14-year old Swiss children by weight classification  
 
 Normal weight Overweight Obese 
n 38 36 50 
Energy (kcal) 1842 ± 4441 1773 ± 227 1809 ± 374 
Total fat (g) 76.1 ± 20.7 69.8 ± 11.6 72.9 ± 19.4 
% energy as fat 36.4 ± 4.7 34.7 ± 4.1 35.5 ± 4.1 
Saturated fatty 
acids (SFA) (g) 
31.8 ± 9.6 27.9 ± 6.5 28.2 ± 7.9 
% energy as SFA 15.3 ± 2.8 a 14.0 ± 2.4 a,b 13.9 ± 2.5 b 
Polyunsaturated 
fatty acids (PUFA) 
(g) 
9.8 ± 3.5 10.1 ± 4.7 10.6 ± 5.7 
% energy as PUFA 4.7 ± 1.2 5.1 ± 1.4 5.2 ± 2.0 
Monounsaturated 
fatty acids (MUFA) 
(g) 
27.2 ± 8.0 24.8 ± 4.8 27.4 ± 8.8 
% energy as MUFA 13.1 ± 2.3 12.5 ± 2.0 13.5 ± 3.5 
Total carbohydrates 
(g) 
228.9 ± 62.9 223.0 ± 38.0 222.6 ± 55.6 
% energy as 
carbohydrates 
50.1 ± 4.9 50.8 ± 4.0 49.8 ± 6.1 
Glucose (g) 12.1 ± 5.7 11.9 ± 5.9 9.8 ± 4.3 
Fructose (g) 15.6 ± 7.6 16.0 ± 8.5 12.4 ± 8.1 
Total protein (g) 59.9 ± 13.2 62.8 ± 9.0 65.5 ± 13.7 
% energy as protein 13.3 ± 2.1 a 14.5 ± 2.2 a,b 14.8 ± 2.3 b 
Vit C (mg) 102.1 ± 49.0 99.2 ± 49.1 92.6 ± 51.0 
Vit E (mg) 4.5 ± 3.3 6.5± 4.1 5.8 ± 4.1 
Total Vit A (mg 
RAE) 
0.82 ± 0.31 a 0.65 ± 0.23 b 0.62 ± 0.30 b 
Meatproducts (g) 63.0 ± 41.4 a 82.3 ± 41.4 a,b 94.8 ± 47.4 b 
Dairy products (g) 306.6 ± 154.3 268.3 ± 136.1 255.4 ± 156.3 
Fruits and 
vegetables (g) 
381.5 ± 182.0 391.2 ± 193.2 321.9 ± 202.9 
 
Means not sharing a common superscript letter are significantly different from each other at 
p<0.05 based on ANOVA and post hoc Bonferroni correction. 
1 mean ± SD (all such values)
Table 3  Univariate and multivariate associations between aP2 and components of the metabolic syndrome in 6 to 14 year old 
children (n=124) 
 
 Fasting insulin QUICKI Triglycerides LDL cholesterol Systolic blood 
pressure 
Diastolic blood 
pressure 
 p r 1 p r p r p r p r p r 
Univariate <0.001 0.444 <0.001 -0.436 <0.001 0.380 <0.001 0.338 <0.001 0.354 0.005 0.266 
 
 p β 2 p β p β p β p β p β 
Multivariate 3 0.617 0.043 0.856 -0.016 0.242 0.088 0.007 0.182 0.799 0.020 0.385 0.062 
1 Pearson correlation coefficient 
2 Standardized coefficient β 
3 Multivariate regression models with log aP2 as the dependent variable and controlled for BMI SDS and pubertal stage 
Table 4 Univariate and multivariate associations between aP2 and inflammatory 
parameters in 6 to 14 year old children (n=124) 
 
 CRP IL6 Leptin 
 p r 1 p r p r 
Univariate <0.001 0.413 0.002 0.352 <0.001 0.753 
       
 p β 2 p β p β 
Multivariate 3 0.023 0.179 0.431 0.077 <0.001 0.671 
1 Pearson correlation coefficient 
2 Standardized coefficient β 
3 Multivariate regression models with log aP2 as the dependent variable and 
controlled for BMI SDS and pubertal stage 
 
 
 23
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Circulating aP2 concentrations by weight classification and by tertiles of 
W/H ratio in 6-14 y-old children. For both, differences between all groups 
are significant (p<0.05). Normal weight (NW) n=38, overweight (OW) n=36, 
obese (OB) n=50. 
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Figure 2  The interactions of circulating aP2 concentrations and dietary intake of 
total fat (a and c) and saturated fat (SFA) (b and d) on concentrations of 
fasting insulin (a and b) and C-reactive protein (c and d) in 6-14 y-old 
normal, overweight and obese children (n=124). Data are presented as 
tertiles for aP2 and dietary fat intakes.  
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